← Eichor
Study identifier: NCT07607964 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Condition: Systemic Lupus Erythematosus · Rheumatoid Arthritis  ·  Sponsor: AbbVie

PhasePhase 1
Planned participants30
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. The purpose of this study is to assess the pharmacokinetics, pharmacodynamics and safety of ABBV-519 in adult participants with SLE or RA. This is a single ascending dose study in an estimated 30 adult participants with moderate SLE or RA. The total duration of the study will be approximately 425 days (60-day Screening Period, 1-day Treatment Period, and a 52 week Follow-up Period) at approximately 15 to 20 sites globally. There may be higher treatment burden for participants in this trial compared to their standard of care (due to study procedures). Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

This description comes directly from the study's public registry record.

Talk to the study team

ABBVIE CALL CENTER  ·  844-663-3742  ·  abbvieclinicaltrials@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (10)

Pinnacle Research Group /ID# 278677Anniston, Alabama, United StatesRecruiting
UCLA Health West Medical Campus /ID# 282811Los Angeles, California, United StatesWithdrawn
Solace Research /ID# 279155Tustin, California, United StatesRecruiting
Clinical Research Of West Florida - Phase I Unit /ID# 279292Clearwater, Florida, United StatesRecruiting
Finlay Medical Research - Greenacres /ID# 278380Greenacres City, Florida, United StatesRecruiting
Clinical Research of Osceola /ID# 278374Kissimmee, Florida, United StatesRecruiting
Discovery Health Research Center /ID# 279691Plantation, Florida, United StatesRecruiting
Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 279130Tampa, Florida, United StatesRecruiting
Advanced Quality Medical Research /ID# 279147Orland Park, Illinois, United StatesRecruiting
Epic Medical Research /ID# 279180Red Oak, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07607964